ACADIA PHARMACEUTICALS INC (ACAD) Stock Earnings & Estimates
NASDAQ:ACAD - US0042251084 - Common Stock
25.72 USD
+0.4 (+1.58%)
25.72 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 517.2M 6.84% | 726.437M 40.46% | 957.797M 31.85% | 1.092B 14.01% | 1.22B 11.72% | 1.365B 11.89% | 1.518B 11.21% | 1.692B 11.46% | 1.763B 4.20% | 2.157B 22.35% | 2.168B 0.51% | |
| EBITDA YoY % growth | -221.57M -32.64% | -67.827M 69.39% | 100.162M 247.67% | 89.57M -10.57% | 154.64M 72.65% | 248.05M 60.40% | 649.82M 161.97% | 873.27M 34.39% | N/A | N/A | N/A | |
| EBIT YoY % growth | -223.6M -31.22% | -73.379M 67.18% | 84.279M 214.85% | 84.999M 0.85% | 131.82M 55.08% | 231.59M 75.69% | 406.63M 75.58% | 574.81M 41.36% | 596.07M 3.70% | 934.38M 56.76% | 992.4M 6.21% | |
| Operating Margin | -43.23% | -10.10% | 8.80% | 7.78% | 10.80% | 16.97% | 26.79% | 33.97% | 33.81% | 43.32% | 45.77% | |
| EPS YoY % growth | -0.97 7.62% | -0.38 60.82% | 0.48 226.32% | 0.58 19.98% | 0.86 50.00% | 1.42 64.71% | 2.19 53.76% | 2.70 23.54% | 2.76 2.26% | 4.01 45.20% | 5.22 29.99% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.15 -27.04% | 0.13 753.72% | 0.11 -1.09% | 0.18 10.50% | 0.13 -9.13% | 0.18 40.43% |
| Revenue Q2Q % growth | 282.07M 12.65% | 292.49M 12.67% | 272.72M 11.63% | 306.21M 15.74% | N/A | N/A |
| EBITDA Q2Q % growth | 25.68M -39.31% | 20.643M -9.74% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 25.1M -20.68% | 20.967M 200.04% | 15.705M -18.58% | 40.192M 24.15% | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.16 -20.00% | 0.14 | 0.02 | 14.46% |
| Q1 2025 Q2Q % growth | 0.11 10.00% | 0.11 | 0.00 | -3.19% |
| Q4 2024 Q2Q % growth | -0.02 -107.14% | 0.22 | -0.24 | -109.07% |
| Q3 2024 Q2Q % growth | 0.20 150.00% | 0.14 | 0.06 | 41.97% |
| Q2 2024 Q2Q % growth | 0.20 1,900.00% | 0.18 | 0.02 | 9.83% |
| Q1 2024 Q2Q % growth | 0.10 137.04% | 0.05 | 0.05 | 109.49% |
| Q4 2023 Q2Q % growth | 0.28 207.69% | 0.31 | -0.03 | -9.66% |
| Q3 2023 Q2Q % growth | -0.40 -135.29% | -0.43 | 0.03 | 7.97% |
| Q2 2023 Q2Q % growth | 0.01 104.76% | -0.08 | 0.09 | 111.87% |
| Q1 2023 Q2Q % growth | -0.27 18.18% | -0.22 | -0.05 | -23.29% |
| Q4 2022 Q2Q % growth | -0.26 3.70% | -0.25 | -0.01 | -4.94% |
| Q3 2022 Q2Q % growth | -0.17 -88.89% | -0.19 | 0.02 | 12.05% |
| Q2 2022 Q2Q % growth | -0.21 22.22% | -0.25 | 0.04 | 16.87% |
| Q1 2022 Q2Q % growth | -0.33 21.43% | -0.61 | 0.28 | 46.18% |
| Q4 2021 Q2Q % growth | -0.27 35.71% | -0.24 | -0.03 | -11.34% |
| Q3 2021 Q2Q % growth | -0.09 83.33% | -0.27 | 0.18 | 66.19% |
| Q2 2021 Q2Q % growth | -0.27 | -0.31 | 0.04 | 13.13% |
| Q1 2021 Q2Q % growth | -0.42 26.32% | -0.54 | 0.12 | 22.52% |
| Q4 2020 Q2Q % growth | -0.42 -23.53% | -0.48 | 0.06 | 12.68% |
| Q3 2020 Q2Q % growth | -0.54 -86.21% | -0.39 | -0.15 | -38.11% |
| Q2 2020 Q2Q % growth | -0.27 28.95% | -0.45 | 0.18 | 40.17% |
| Q1 2020 Q2Q % growth | -0.57 3.39% | -0.49 | -0.08 | -16.35% |
| Q4 2019 Q2Q % growth | -0.34 | -0.37 | 0.03 | 8.14% |
| Q3 2019 Q2Q % growth | -0.29 | -0.41 | 0.12 | 29.19% |
| Q2 2019 Q2Q % growth | -0.38 | -0.46 | 0.08 | 18.04% |
| Q1 2019 Q2Q % growth | -0.59 | -0.54 | -0.05 | -10.27% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 264.566M 9.34% | 267.05M | -2.484M | -0.93% |
| Q1 2025 Q2Q % growth | 244.317M 18.70% | 244.12M | 197K | 0.08% |
| Q4 2024 Q2Q % growth | 259.602M 12.36% | 283.2M | -23.598M | -8.33% |
| Q3 2024 Q2Q % growth | 250.401M 18.28% | 253.79M | -3.389M | -1.34% |
| Q2 2024 Q2Q % growth | 241.963M 46.44% | 240.37M | 1.593M | 0.66% |
| Q1 2024 Q2Q % growth | 205.831M 73.75% | 212.46M | -6.629M | -3.12% |
| Q4 2023 Q2Q % growth | 231.041M 69.26% | 228.26M | 2.781M | 1.22% |
| Q3 2023 Q2Q % growth | 211.699M 61.97% | 193.28M | 18.419M | 9.53% |
| Q2 2023 Q2Q % growth | 165.235M 22.76% | 160.96M | 4.275M | 2.66% |
| Q1 2023 Q2Q % growth | 118.462M 2.56% | 122.69M | -4.228M | -3.45% |
| Q4 2022 Q2Q % growth | 136.5M 4.36% | 136.75M | -250K | -0.18% |
| Q3 2022 Q2Q % growth | 130.7M -0.68% | 141.42M | -10.72M | -7.58% |
| Q2 2022 Q2Q % growth | 134.6M 16.84% | 133.04M | 1.56M | 1.17% |
| Q1 2022 Q2Q % growth | 115.5M 8.35% | 124.35M | -8.85M | -7.12% |
| Q4 2021 Q2Q % growth | 130.8M 8.10% | 138.1M | -7.3M | -5.29% |
| Q3 2021 Q2Q % growth | 131.6M 9.12% | 130.31M | 1.29M | 0.99% |
| Q2 2021 Q2Q % growth | 115.2M 4.63% | 127.44M | -12.24M | -9.60% |
| Q1 2021 Q2Q % growth | 106.6M 18.31% | 113.87M | -7.27M | -6.38% |
| Q4 2020 Q2Q % growth | 121M 23.09% | 125.67M | -4.67M | -3.72% |
| Q3 2020 Q2Q % growth | 120.6M 27.48% | 121.2M | -600K | -0.50% |
| Q2 2020 Q2Q % growth | 110.1M 32.33% | 105.41M | 4.69M | 4.45% |
| Q1 2020 Q2Q % growth | 90.1M 43.02% | 92.894M | -2.794M | -3.01% |
| Q4 2019 Q2Q % growth | 98.3M | 98.698M | -398K | -0.40% |
| Q3 2019 Q2Q % growth | 94.6M | 90.257M | 4.343M | 4.81% |
| Q2 2019 Q2Q % growth | 83.2M | 73.568M | 9.632M | 13.09% |
| Q1 2019 Q2Q % growth | 63M | 61.901M | 1.099M | 1.78% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.67% | -31.78% | 7.65% | -3.06% |
| Revenue | 0.83% | 2.33% | 0.65% | 0.46% |